Clinical Trial Update: Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of brachytherapy using iodine-125 seeds with the PARP inhibitor fluzoparib for advanced unresectable soft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Fluzoparib (fluzoparib)

Snippet

Sponsor: Fujun Zhang | Conditions: Sarcoma,Soft Tissue, Brachytherapy | Phase 2 | Status: RECRUITING